NEW YORK--(BUSINESS WIRE)--Lev Pharmaceuticals, Inc. (“Lev”) (OTCBB: LEVP) today announced financial results for the fourth quarter and fiscal year ended December 31, 2007. Lev will conduct a conference call and audio webcast at 1:00 p.m. Eastern Time (ET) this afternoon to discuss its financial results and to provide an update on its lead product candidate, Cinryze™ (C1 inhibitor). The call will be webcast live and may be accessed by visiting the company’s website at www.levpharma.com. A replay will be available for a limited time following the live call.
